Their own payment-practices filing · gov.uk
Oxford Biomedica (UK) Limited pays suppliers in 22 days on average — inside its 30-day stated terms
Their H1 2026 filing puts the average 8 days inside their stated 30-day term.
- Their stated terms
- 30 days
- Paid outside agreed terms
- 17% of invoices
- Paid after 61+ days
- 1%
- Reporting period
- 1 Jan 2026 – 30 Jun 2026
- Source
- their gov.uk filing, filed 31 Jul 2026
Self-reported figures from their statutory filing. How this is compiled.
Terms vs reality · their H1 2026 filing
Paid 8 days inside the 30-day term they state
Where their invoices landed · share of all invoices
The pattern · last 6 of 17 reports
26 → 22 days — getting faster
The read · computed from their figures
Oxford Biomedica (UK) Limited's H1 2026 filing puts their average at 22 days against stated terms of 30 days; 17% of invoices were paid outside agreed terms and 1% took 61 days or longer. Filed 31 Jul 2026.
The direction is faster: from 26 days in H2 2023 to 22 now — 4 days faster across their last 6 reports.
On the latest reported averages: Faster than 96% of the 977 large companies reporting in manufacturing.
That is 17 statutory periods on record (earliest H1 2018) — a historical record, not a promise for a new invoice.
In their own words · from the filing
Standard payment terms
Various payment terms across suppliers but 30 days is the most common.
Dispute resolution
Disputes may (most commonly) arise in respect of the testing of consumables used within OXB's drug manufacture process. In this context disputes are led by the operational/scientific elements of the business in collaboration with suppliers.
Every statutory report on record
Most recent first.
| Period | Avg days | Outside terms | 61+ days | Filed |
|---|---|---|---|---|
| H1 2026 | 22 | 17% | 1% | 31 Jul 2026 |
| H2 2025 | 21 | 18% | 2% | 30 Jan 2026 |
| H1 2025 | 20 | 14% | 1% | 31 Jul 2025 |
| H2 2024 | 22 | 13% | 3% | 3 Feb 2025 |
| H1 2024 | 24 | 15% | 7% | 18 Dec 2024 |
| H2 2023 | 26 | 20% | 11% | 19 Dec 2024 |
| H1 2023 | 28 | 24% | 12% | 19 Dec 2024 |
| H2 2022 | 28 | 23% | 23% | 19 Dec 2024 |
| H1 2022 | 29 | 31% | 11% | 19 Dec 2024 |
| H2 2021 | 26 | 21% | 15% | 19 Dec 2024 |
| H1 2021 | 29 | 26% | 13% | 19 Dec 2024 |
| H2 2020 | 29 | 30% | 13% | 19 Dec 2024 |
| H1 2020 | 30 | 28% | 15% | 19 Dec 2024 |
| H2 2019 | 28 | 19% | 18% | 19 Dec 2024 |
| H1 2019 | 30 | 20% | 23% | 19 Dec 2024 |
| H2 2018 | 32 | 44% | 18% | 19 Dec 2024 |
| H1 2018 | 29 | 37% | 10% | 19 Dec 2024 |
On the public register · Companies House
Company record
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 3 Mar 1995
- Registered office
- WINDRUSH COURT, OXFORD, OX4 6LT
Quick answers · Oxford Biomedica (UK) Limited
Are they getting slower or faster?
What's their typical pay point?
Can I see what this means for my invoices?
Stay ahead
Watch Oxford Biomedica (UK) Limited (free)
Their next payment report is due ≈ 26 Jan 2027. We watch their public record and email you when something changes — a new payment report, late filings, insolvency markers, new charges.
You’ll get a confirmation email first. Unsubscribe any time. How we handle your address.
More large companies in manufacturing
Owen Mumford Limited · Oxford Instruments Nanotechnology Tools Limited · Osi Food Solutions UK Limited · Oxoid Limited · Oscar Mayer Limited · Pall Europe Limited
How UK payment reporting works
What is a Payment Practices Report?
What does "paid outside agreed terms" mean?
How often is this data updated?
Is this official government data?
How this is compiled. Built from official records only: Companies House and the gov.uk payment-practices service. The payment figures are self-reported — companies over the size threshold must file them by law and the board signs them off. No credit-agency data. The numbers are theirs; the plain-English read is ours. This is information compiled from public records under the Open Government Licence v3.0 — not a credit rating and not advice.
The 31-day comparison figure is the median across 6,104 companies with a current statutory report — every sector pooled, not an average of sector medians (how the figure is built).
Report PL-03028927 · latest period to 30 Jun 2026
Built by YORXEN LTD · registered in England & Wales · CRN 17303256 · privacy · terms.